Skip NavigationSkip to Content

3,7-Dihydroxytropolones Inhibit Initiation of Hepatitis B Virus Minus-Strand DNA Synthesis

  1. Author:
    Bak, Ellen
    Miller,Jennifer
    Noronha, Andrea
    Tavis, John
    Gallicchio, Emilio
    Murelli, Ryan P
    Le Grice,Stuart
  2. Author Address

    Basic Research Laboratory National Cancer Institute, Frederick, MD 21702, USA., Department of Molecular Microbiology and Immunology, St. Louis University, St. Louis, MO 63104, USA., Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, NY 11210, USA., PhD Program in Chemistry, The Graduate Center of The City University of New York, New York, NY 10016, USA., PhD Program in Biochemistry, The Graduate Center of The City University of New York, New York, NY 10016, USA.,
    1. Year: 2020
    2. Date: OCT
    3. Epub Date: 2020 09 27
  1. Journal: Molecules (Basel, Switzerland)
    1. 25
    2. 19
    3. Pages: pii: E4434
  2. Type of Article: Article
  3. Article Number: 4434
  4. ISSN: 1420-3049
  1. Abstract:

    Initiation of protein-primed (-) strand DNA synthesis in hepatitis B virus (HBV) requires interaction of the viral reverse transcriptase with epsilon (e), a cis-acting regulatory signal located at the 5 39; terminus of pre-genomic RNA (pgRNA), and several host-encoded chaperone proteins. Binding of the viral polymerase (P protein) to e is necessary for pgRNA encapsidation and synthesis of a short primer covalently attached to its terminal domain. Although we identified small molecules that recognize HBV e RNA, these failed to inhibit protein-primed DNA synthesis. However, since initiation of HBV (-) strand DNA synthesis occurs within a complex of viral and host components (e.g., Hsp90, DDX3 and APOBEC3G), we considered an alternative therapeutic strategy of allosteric inhibition by disrupting the initiation complex or modifying its topology. To this end, we show here that 3,7-dihydroxytropolones (3,7-dHTs) can inhibit HBV protein-primed DNA synthesis. Since DNA polymerase activity of a ribonuclease (RNase H)-deficient HBV reverse transcriptase that otherwise retains DNA polymerase function is also abrogated, this eliminates direct involvement of RNase (ribonuclease) H activity of HBV reverse transcriptase and supports the notion that the HBV initiation complex might be therapeutically targeted. Modeling studies also provide a rationale for preferential activity of 3,7-dHTs over structurally related a-hydroxytropolones (a-HTs).

    See More

External Sources

  1. DOI: 10.3390/molecules25194434
  2. PMID: 32992516
  3. WOS: 000586774100001
  4. PII : molecules25194434

Library Notes

  1. Fiscal Year: FY2020-2021
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel